Grifols Therapeutics LLC
Clayton, NC
- UEI
- UFQ3A7GKJ5C7
- CAGE
- 6SLC6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 8368 Clayton Blvd, Clayton, NC 27520, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $613,200 |
| FY2023 | -$83,318 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Grifols USA LLC | Los Angeles, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| Ionis Pharmaceuticals, Inc. | Carlsbad, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Adma Biologics, Inc. | Ramsey, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Grifols Therapeutics LLC is a for-profit corporate entity registered in the System for Award Management (SAM), headquartered in Durham, North Carolina. The company is a manufacturer of pharmaceuticals and biopharmaceuticals, specializing in producing medical products such as immunoglobulins, respiratory therapeutics, and specialized medical treatments. As a limited liability company with a robust federal contracting presence, Grifols has established itself as a key supplier to various federal agencies, demonstrating consistent capability in delivering medical and pharmaceutical products through government contract vehicles.
The federal contract awards for Grifols Therapeutics LLC primarily focus on pharmaceutical product deliveries, with a significant concentration of contracts from the Department of Veterans Affairs (VA) Veterans Health Administration. The company has consistently provided products like PROLASTIN, PROLASTIN-C, and immune globulin through delivery orders under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). These contracts, ranging from $1,314.80 to $454,461.44, have not utilized small business set-asides. Additionally, Grifols has secured a notable contract with the Office of the Assistant Secretary for Preparedness and Response for ocular surface immunoglobulin to manage injuries from vesicant agents, valued at $613,200.00. The contract awards demonstrate the company's expertise in supplying specialized medical treatments and pharmaceuticals to federal agencies, with a track record of delivering high-value, mission-critical medical products across different government sectors.
Quick answers
Is Grifols Therapeutics LLC registered in SAM.gov?
Yes. Grifols Therapeutics LLC's SAM.gov registration is active through April 22, 2027.
Which contract vehicles does Grifols Therapeutics LLC hold?
Grifols Therapeutics LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Grifols Therapeutics LLC received in federal contracts?
Federal contracts obligated $529,882 to Grifols Therapeutics LLC in fiscal years 2023 through 2027.
What is Grifols Therapeutics LLC's most recent federal award?
Grifols Therapeutics LLC's most recent federal contract award is Grifols therapeutics LLC- ocular surface immunoglobulin in the management of vesicant agents injury (75A50124C00050), from Office of the Assistant Secretary for Preparedness and Response, on September 27, 2024.
On GovTribe
See Grifols Therapeutics LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors